Comprehensive identification of reported blood transcriptional biomarkers of viral infection by systematic review, and their application in standardised SARS-CoV-2 and influenza human challenges with high frequency sampling are major strengths of this study, thus enabling identification of differential temporal profiles of MX1 and IFI27 responses. Here, IFI27 is linked to viral infectious disease.